Earningsreport

Q3/2024 9/30/2024 EPS 0.120 ZacksConsensus -0.120 ActVsEst 0.240 - Beat

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors